Maghsudlu Mohaddese, Farashahi Yazd Ehsan, Amiriani Taghi
Stem Cell Biology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
J Gastrointest Cancer. 2020 Mar;51(1):227-233. doi: 10.1007/s12029-019-00232-x.
Esophageal squamous cell carcinoma (ESCC) is one of the predominant types of esophageal cancer with poor prognosis which shows high prevalence in eastern countries. Studying microRNAs that were considered for their capabilities such as tissue-specific expression and involvement in different cell features may be informative in the field of diagnostic and prognostic tumor markers. The expression levels of miR-27a and miR-24-2 have been reported to be dysregulated in various cancers and contribute in tumorigenesis and progression; thus, evaluating their expressional behavior and its association with tumor states alteration in ESCC could potentially be helpful.
The study was conducted on 30 fresh specimens including tumor and normal counterparts' tissues of ESCC. After the extraction of total RNA, complementary DNA synthesis was performed by the use of linear specific primers. Eventually, real-time polymerase chain reaction was carried out for the measurement of microRNAs expression level.
According to the obtained data, miR 27a and miR-24-2 were significantly upregulated (~2.5 fold, p < 0.05) in tumor specimens compared with their normal adjacent tissue; Moreover, upregulation of miR-27a and 24-2 showed cooperative relationship while analyzed. However, there was no correlation between clinicopathological features and microRNAs upregulation.
The results of this study show that miR-27a and miR-24-2 cooperatively upregulate in ESCC and suggest that these microRNAs can be introduced as a candidate for further study in the field of screening and prognostic biomarkers.
食管鳞状细胞癌(ESCC)是食管癌的主要类型之一,预后较差,在东方国家发病率较高。研究具有组织特异性表达和参与不同细胞特征等能力的微小RNA,可能为肿瘤诊断和预后标志物领域提供信息。据报道,miR-27a和miR-24-2的表达水平在各种癌症中失调,并在肿瘤发生和进展中起作用;因此,评估它们在ESCC中的表达行为及其与肿瘤状态改变的关联可能会有所帮助。
对30份新鲜标本进行研究,包括ESCC的肿瘤组织和相应的正常组织。提取总RNA后,使用线性特异性引物进行互补DNA合成。最后,进行实时聚合酶链反应以测量微小RNA的表达水平。
根据获得的数据,与正常相邻组织相比,肿瘤标本中miR 27a和miR-24-2显著上调(约2.5倍,p < 0.05);此外,分析时miR-27a和24-2的上调显示出协同关系。然而,临床病理特征与微小RNA上调之间没有相关性。
本研究结果表明,miR-27a和miR-24-2在ESCC中协同上调,并表明这些微小RNA可作为筛选和预后生物标志物领域进一步研究的候选物。